United States

Embecta Corp (EMBC)

Track

Track

Embecta Corp experienced significant insider trading activity recently, with executives purchasing shares following a strong earnings report. Net buying totaled over $520,000, led by the CEO and CFO. Conversely, a director executed minor sales. These movements occurred amid a 74.9% stock price increase over the last quarter.
Ticker: EMBC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Embecta Corp. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Morris Milton Mayo Non-Executive Director
Transaction date
Sale
Price
296.20
Quantity 41,482 +28.8%
Value US$3,303,000
2.9
Morris Milton Mayo Director Non-Executive Director
Transaction date
Proposed sale
Price
444.19
Quantity 92,184
Value US$2,574,730
1.1
Kurdikar Devdatt President and CEO Executive Director
Transaction date
Purchase
Price
400.08
Quantity 34,333 -7.1%
Value US$2,575,494
1.1
Elguicze Jacob SVP and CFO Officer
Transaction date
Purchase
Price
4.67
Quantity 20,000 +6.9%
Value US$93,360
0.9
Mann Jeffrey Z Pres, Pharm Svc&Prod Mgmt, CLO Officer
Transaction date
Purchase
Price
4.99
Quantity 20,000 +8.2%
Value US$99,800
HOMBACH ROBERT J. Non-Executive Director
Transaction date
Purchase
Price
4.97
Quantity 45,000 +69.7%
Value US$223,848
2.4
Melcher David F Non-Executive Director
Transaction date
Purchase
Price
10.60
Quantity 10,000 +13.0%
Value US$105,995
2.4
Melcher David F Non-Executive Director
Transaction date
Purchase
Price
13.67
Quantity 13,000 +20.4%
Value US$177,646
2.9
Morris Milton Mayo Non-Executive Director
Transaction date
Sale
Price
16.38
Quantity 3,100 -7.9%
Value US$50,783
2.9
Morris Milton Mayo Director Non-Executive Director
Transaction date
Proposed sale
Price
16.38
Quantity 3,100
Value US$50,778
2.4
Melcher David F Non-Executive Director
Transaction date
Purchase
Price
16.25
Quantity 2,000 +4.6%
Value US$32,500
2.4
Melcher David F Non-Executive Director
Transaction date
Purchase
Price
15.77
Quantity 6,233 +29.0%
Value US$98,271
1.1
Kurdikar Devdatt President and CEO Executive Director
Transaction date
Purchase
Price
21.81
Quantity 5,000 +2.1%
Value US$109,050
1.1
Elguicze Jacob SVP and CFO Officer
Transaction date
Purchase
Price
21.66
Quantity 4,625 +7.5%
Value US$100,195
0.9
Mann Jeffrey Z SVP, GC, Head Corp. Dev., Secy Officer
Transaction date
Purchase
Price
21.67
Quantity 4,700 +9.3%
Value US$101,849
2.4
Melcher David F Non-Executive Director
Transaction date
Purchase
Price
32.51
Quantity 3,100 +16.9%
Value US$100,781
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-08 2026-09-04 S Sale
2.9
Morris Milton Mayo
Non-Executive Director
41,482 +28.8%
296.20
US$3,303,000 		41,482 +28.8% 296.20 US$3,303,000
2026-09-04 2026-09-04 PrS Proposed sale
2.9
Morris Milton Mayo

Director

Non-Executive Director
92,184
444.19
US$2,574,730 		92,184 444.19 US$2,574,730
2026-08-13 2026-08-12 B Purchase
1.1
Kurdikar Devdatt

President and CEO

Executive Director
34,333 -7.1%
400.08
US$2,575,494 		34,333 -7.1% 400.08 US$2,575,494
2026-08-13 2026-08-12 B Purchase
1.1
Elguicze Jacob

SVP and CFO

Officer
20,000 +6.9%
4.67
US$93,360 		20,000 +6.9% 4.67 US$93,360
2026-08-13 2026-08-12 B Purchase
0.9
Mann Jeffrey Z

Pres, Pharm Svc&Prod Mgmt, CLO

Officer
20,000 +8.2%
4.99
US$99,800 		20,000 +8.2% 4.99 US$99,800
2026-08-13 2026-08-12 B Purchase
HOMBACH ROBERT J.
Non-Executive Director
45,000 +69.7%
4.97
US$223,848 		45,000 +69.7% 4.97 US$223,848
2025-05-23 2025-05-23 B Purchase
2.4
Melcher David F
Non-Executive Director
10,000 +13.0%
10.60
US$105,995 		10,000 +13.0% 10.60 US$105,995
2025-02-25 2025-02-25 B Purchase
2.4
Melcher David F
Non-Executive Director
13,000 +20.4%
13.67
US$177,646 		13,000 +20.4% 13.67 US$177,646
2025-02-14 2025-02-13 S Sale
2.9
Morris Milton Mayo
Non-Executive Director
3,100 -7.9%
16.38
US$50,783 		3,100 -7.9% 16.38 US$50,783
2025-02-13 2025-02-13 PrS Proposed sale
2.9
Morris Milton Mayo

Director

Non-Executive Director
3,100
16.38
US$50,778 		3,100 16.38 US$50,778
2024-02-12 2024-02-12 B Purchase
2.4
Melcher David F
Non-Executive Director
2,000 +4.6%
16.25
US$32,500 		2,000 +4.6% 16.25 US$32,500
2023-09-08 2023-09-08 B Purchase
2.4
Melcher David F
Non-Executive Director
6,233 +29.0%
15.77
US$98,271 		6,233 +29.0% 15.77 US$98,271
2023-08-10 2023-08-10 B Purchase
1.1
Kurdikar Devdatt

President and CEO

Executive Director
5,000 +2.1%
21.81
US$109,050 		5,000 +2.1% 21.81 US$109,050
2023-08-10 2023-08-10 B Purchase
1.1
Elguicze Jacob

SVP and CFO

Officer
4,625 +7.5%
21.66
US$100,195 		4,625 +7.5% 21.66 US$100,195
2023-08-10 2023-08-10 B Purchase
0.9
Mann Jeffrey Z

SVP, GC, Head Corp. Dev., Secy

Officer
4,700 +9.3%
21.67
US$101,849 		4,700 +9.3% 21.67 US$101,849
2023-02-15 2023-02-15 B Purchase
2.4
Melcher David F
Non-Executive Director
3,100 +16.9%
32.51
US$100,781 		3,100 +16.9% 32.51 US$100,781
Explore more

More insider trading research around Embecta Corp

More insider trades in United States
Insider trading in North America